JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB273379

Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line

Be the first to review this product! Submit a review

|

(1 Publication)

IL1RN KO cell line available to order. KO validated by Immunocytochemistry, Western blot. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 49 bp deletion in exon 5. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

ICIL-1RA, IL-1ra3, IL1F3, IRAP, MGC10430, intracellular IL-1 receptor antagonist type II, intracellular interleukin-1 receptor antagonist, type II interleukin-1 receptor antagonist

6 Images
Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)
  • WB

Lab

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)

False colour image of Western blot : Anti-IL-1RA antibody [EPR6483] staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab124962 was shown to bind specifically to IL-1RA. A band was observed at 19 kDa in wild-type A431 cell lysates with no signal observed at this size in IL1RN knockout cell line ab273379 (knockout cell lysate ab275530). To generate this image, wild-type and IL1RN knockout A431 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween™ 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-IL-1RA antibody [EPR6483] (<a href='/en-us/products/primary-antibodies/il-1ra-antibody-epr6483-ab124962'>ab124962</a>) at 1/10000 dilution

Lane 1:

Wild-type A431 cell lysate at 20 µg

Lane 2:

IL-1RA knockout A431 cell lysate at 20 µg

Lane 2:

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (ab273379)

Predicted band size: 20 kDa

Observed band size: 19 kDa

false

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)
  • WB

Lab

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)

All lanes:

Western blot - Anti-IL-1RA antibody [EPR6483] (<a href='/en-us/products/primary-antibodies/il-1ra-antibody-epr6483-ab124962'>ab124962</a>) at 1/50000 dilution

Lane 1:

Wild-type A431 cell lysate at 20 µg

Lane 2:

IL1RN knockout A431 cell lysate at 20 µg

Lane 2:

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (ab273379)

Lane 3:

MOLT-4 cell lysate at 20 µg

Lane 4:

Human Kidney cell lysate at 20 µg

Secondary

Lanes 1 - 4:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 4:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 18 kDa

false

Immunocytochemistry - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)
  • ICC

Lab

Immunocytochemistry - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)

IL-1RA staining observed in wild-type A431 cells (top panel) and IL1RN knockout A431 cells (bottom panel). The cells were fixed with 100% methanol (5 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with an anti-IL-1ra antibody at 10μg/ml concentration (shown in green) and ab195889 (Mouse monoclonal to alpha Tubulin - Alexa Fluor® 594) at 1/250 dilution (shown in red) overnight at 4°C. Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).

Sandwich ELISA - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)
  • sELISA

Lab

Sandwich ELISA - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)

Human IL-1RA concentration was interpolated from the IL-1RA standard curve. Supernatants from cell culture samples were serially diluted and assessed by the Human IL-1ra ELISA Kit (ab211650). Wild-type A-431, IL1RN knockout A-431 (ab273379) and THP-1 cells were assessed in duplicate (n=2). Data are represented as the mean and error bars represent standard deviation.

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)
  • WB

Lab

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)

Lanes 1 - 4 : Merged signal (red and green). Green - Anti-IL-1ra antibody observed at 18 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
Anti-IL-1ra antibody was shown to react with IL-1ra in wild-type A431 cells in Western blot with loss of signal observed in IL-1RA knockout cell line ab273379 (IL-1RA knockout cell lysate ab275530). Wild-type A431 and IL-1RA knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with anti-IL-1ra antibody and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at 0.5 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Donkey anti-Goat IgG H&L (IRDye® 800CW) preabsorbed (ab216775) and Donkey anti-Mouse 680RD secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Anti-IL-1ra antibody at 0.5 µg/mL

Lane 1:

Wild-type A431 cell lysate at 20 µg

Lane 2:

IL-1RA knockout A431 cell lysate at 20 µg

Lane 2:

Western blot - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (ab273379)

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

SK-OV-3 cell lysate at 20 µg

false

Sanger Sequencing - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)
  • Sanger seq

Unknown

Sanger Sequencing - Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line (AB273379)

49 bp deletion in exon 5

Key facts

Cell type

A-431

Species or organism

Human

Tissue

Skin

Form

Liquid

form

Knockout validation

Immunocytochemistry,Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 49 bp deletion in exon 5.

Disease

Epidermoid Carcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab273379-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab275462 Human wild-type A-431 cell line", "number":"AB273379-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab273379 Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line", "number":"AB273379-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab273379-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab273379 Human IL1RN (IL1 Receptor Antagonist) knockout A-431 cell line", "number":"AB273379-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
IL1RN
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Immunocytochemistry, Sanger Sequencing, Western blot
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Molecular genetics and genomics : MGG 300:46 PubMed40304806

2025

Identification of oxidative stress-related subgroups and signature genes for the prediction of prognosis and immune microenvironment in thyroid cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenwei Qiu,Jing Li,Mei Tian
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com